The History of Institute of Cancer Research
The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years.
It is a world leader in identifying cancer genes, discovering cancer drugs, and developing precision radiotherapy. Together with its hospital partner The Royal Marsden NHS Foundation Trust, ICR is rated in the top four centers for cancer research and treatment worldwide.
In addition to being a world-class research institute, the ICR is a higher education institution and a college of the University of London. It came top in the league table of university research quality compiled from the Research Excellence Framework(REF 2014). Furthermore, It has charitable status and relies on support from partner organizations, charities, donors and the general public.
The course is made up of three elements, Part A, B, and C, each taking one academic year to complete.
Parts A and B are made up of teaching modules which contribute credits towards the overall course mark. Each module ends in a summative assessment - single best answer papers and/or an essay - which you must successfully complete in order to pass the module. Part A focuses on basic cancer science and is normally studied before Part B, which focuses on the clinical aspects of oncology. Exit after Part A will result in you being awarded the Postgraduate Certificate (PCert). Exit after Part B will result in you being awarded the Postgraduate Diploma (PGDip).
Life in Institute of Cancer Research
ICR ranked among top five in the world for university research. The Institute of Cancer Research, London, has ranked in the top five higher education institutions in the world for research in a new independent evaluation funded by the European Commission
Further eligibility criteria may apply to specific programmes and projects. Carefully read any information provided by the funding body and the project proposals.
- Dr. James Mui - completed his PhD in medicinal chemistry
- Heba Saliem - completed her PhD at The Institute of Cancer Research in 2014.
- Fiona Rowan - was awarded her PhD in Biology and Chemistry at The Institute of Cancer Research in 2014.
- Dan Lloyd - Professor Dan Ll completed his PhD at The Institute of Cancer Research in 1998.
- Ana-Teresa Maia - completed her PhD at The Institute of Cancer Research in 2003. She is now the Vice-Director of the Centre for Biomedical Research at the University of Algarve.
- Olliver Rausch - completed his PhD at The Institute of Cancer Research in 1997.
Institute of Cancer Research Rate 22%